Anderman Todd sold OCUL
October 8, 2026 · Form 4 insider transaction
Anderman Todd sold 11,984 shares of Ocular Therapeutix, Inc. at $7.29 per share, a transaction worth $87.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.
Footnotes
Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on October 7, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on October 7, 2026. The sales do not represent a discretionary trade by the reporting person.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.1000 to $7.4500, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.